4/A: Agilon Health CFO Jeffrey A. Schwaneke Amends Beneficial Ownership Report
SEC Form 4/A Amendment
Jeffrey A. Schwaneke, CFO of Agilon Health, amends a previous filing to clarify details regarding stock purchases and holdings, including transactions made through a family trust and vesting schedules for restricted stock units and options.
Summary
- Jeffrey A. Schwaneke, the CFO of Agilon Health, filed an amendment to a previous Form 4 filing.
- The amendment clarifies that 22,300 shares of common stock purchased on November 29, 2023, were acquired by and are held in the Schwaneke Family Joint Spousal Trust.
- The filing also details restricted stock units vesting in three equal installments starting April 1, 2025, totaling 428,922 shares.
- It includes performance stock units that may vest based on the company's stock price performance within three years from the grant date.
- Additionally, the filing reports options to buy 673,077 shares of common stock at an exercise price of $4.08, vesting in three equal installments beginning April 1, 2025.
- The total direct holdings include 1,130,552 shares, encompassing restricted stock units and performance stock units.
Sentiment
Score: 7
Explanation: The filing is a routine amendment to clarify details of stock transactions, indicating standard corporate governance practices and insider confidence. The vesting schedules suggest a long-term commitment from the CFO.
Positives
- The CFO's holdings demonstrate a vested interest in the company's long-term performance.
- The vesting schedules for restricted stock units and options align with a multi-year commitment to the company.
Future Outlook
The vesting of restricted stock units and performance stock units is contingent upon continued employment and, in the case of performance stock units, the company's stock price performance.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors regarding management's stake in the company.
Comparison to Industry Standards
- Stock option and RSU grants are a common form of compensation for executives in publicly traded companies, such as Agilon Health.
- Vesting schedules, like the three-year vesting period for the reported RSUs and options, are typical in the industry to incentivize long-term commitment.
- Companies like UnitedHealth Group (UNH) and Humana (HUM) also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the CFO's holdings and alignment with company performance.
- Employees may be indirectly impacted by the vesting of performance stock units, which are tied to the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 11/29/2023 | Purchase of 22,300 shares of common stock by the Schwaneke Family Joint Spousal Trust. |
| 11/30/2023 | Date of original filing that is being amended. |
| 04/01/2025 | First vesting date for restricted stock units and stock options. |
| 04/03/2025 | Date of the amended filing. |
| 04/01/2035 | Expiration date for stock options. |
Keywords
Form 4, amendment, beneficial ownership, Agilon Health, AGL, Jeffrey A. Schwaneke, CFO, stock options, restricted stock units, performance stock units, Schwaneke Family Joint Spousal Trust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.